Overview
The control layer across every hypertension treatment pathway. One cheek swab, two decisions, led by renal denervation responder selection, plus medication response guidance.
Funding
Amounts as reported; USD estimates shown only when they match- Latest round
- $1
- 2026-10
- Records
- 1
- 1 month · all drawn
Data noteListed 1 funding record. Latest funding: $1, Oct 21, 2026.
| Date | Funding estimate | Consideration (USD) | Investors | Sources |
|---|---|---|---|---|
| Oct 21, 2026 | $1 | — | Xcellerant Ventures | 1 source Source ↗ |
Evidence Geneticure Completes $1 million other FinancingOn 2026-10-21, according to fireround, Geneticure raises $1 million other. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| ||||
Select ▸ on a row to see its source brief and links.
Team, products & investors
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
The control layer across every hypertension treatment pathway. One cheek swab, two decisions, led by renal denervation responder selection, plus medication response guidance.